Literature DB >> 18263816

Vaccination with F1-V fusion protein protects black-footed ferrets (Mustela nigripes) against plague upon oral challenge with Yersinia pestis.

Tonie E Rocke1, Susan Smith, Paul Marinari, Julie Kreeger, Jeffrey T Enama, Bradford S Powell.   

Abstract

Previous studies have established that vaccination of black-footed ferrets (Mustela nigripes) with F1-V fusion protein by subcutaneous (SC) injection protects the animals against plague upon injection of the bacterium Yersinia pestis. This study demonstrates that the F1-V antigen can also protect ferrets against plague contracted via ingestion of a Y. pestis-infected mouse, a probable route for natural infection. Eight black-footed ferret kits were vaccinated with F1-V protein by SC injection at approximately 60 days-of-age. A booster vaccination was administered 3 mo later via SC injection. Four additional ferret kits received placebos. The animals were challenged 6 wk after the boost by feeding each one a Y. pestis-infected mouse. All eight vaccinates survived challenge, while the four controls succumbed to plague within 3 days after exposure. To determine the duration of antibody postvaccination, 18 additional black-footed ferret kits were vaccinated and boosted with F1-V by SC injection at 60 and 120 days-of-age. High titers to both F1 and V (mean reciprocal titers of 18,552 and 99,862, respectively) were found in all vaccinates up to 2 yr postvaccination, whereas seven control animals remained antibody negative throughout the same time period.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18263816     DOI: 10.7589/0090-3558-44.1.1

Source DB:  PubMed          Journal:  J Wildl Dis        ISSN: 0090-3558            Impact factor:   1.535


  9 in total

1.  Development of a vaccinia virus based reservoir-targeted vaccine against Yersinia pestis.

Authors:  Debaditya Bhattacharya; Joan Mecsas; Linden T Hu
Journal:  Vaccine       Date:  2010-09-25       Impact factor: 3.641

2.  Protection against pneumonic plague following oral immunization with a non-replicating vaccine.

Authors:  Abby Jones; Catharine Bosio; Angela Duffy; Andrew Goodyear; Martin Schriefer; Steven Dow
Journal:  Vaccine       Date:  2010-06-19       Impact factor: 3.641

Review 3.  Protecting against plague: towards a next-generation vaccine.

Authors:  E D Williamson; P C F Oyston
Journal:  Clin Exp Immunol       Date:  2013-04       Impact factor: 4.330

4.  Age at Vaccination May Influence Response to Sylvatic Plague Vaccine (SPV) in Gunnison's Prairie Dogs (Cynomys gunnisoni).

Authors:  Tonie E Rocke; Dan Tripp; Faye Lorenzsonn; Elizabeth Falendysz; Susan Smith; Judy Williamson; Rachel Abbott
Journal:  Ecohealth       Date:  2015-01-15       Impact factor: 4.464

5.  Mitigating amphibian disease: strategies to maintain wild populations and control chytridiomycosis.

Authors:  Douglas C Woodhams; Jaime Bosch; Cheryl J Briggs; Scott Cashins; Leyla R Davis; Antje Lauer; Erin Muths; Robert Puschendorf; Benedikt R Schmidt; Brandon Sheafor; Jamie Voyles
Journal:  Front Zool       Date:  2011-04-18       Impact factor: 3.172

6.  Wildlife mortality investigation and disease research: contributions of the USGS National Wildlife Health Center to endangered species management and recovery.

Authors:  Christopher J Brand
Journal:  Ecohealth       Date:  2014-01-14       Impact factor: 3.184

7.  The Cranial Morphology of the Black-Footed Ferret: A Comparison of Wild and Captive Specimens.

Authors:  Tyler Antonelli; Carissa L Leischner; Adam Hartstone-Rose
Journal:  Animals (Basel)       Date:  2022-10-09       Impact factor: 3.231

8.  Prior infection does not improve survival against the amphibian disease Chytridiomycosis.

Authors:  Scott D Cashins; Laura F Grogan; Michael McFadden; David Hunter; Peter S Harlow; Lee Berger; Lee F Skerratt
Journal:  PLoS One       Date:  2013-02-22       Impact factor: 3.240

9.  Sylvatic plague vaccine: a new tool for conservation of threatened and endangered species?

Authors:  Rachel C Abbott; Jorge E Osorio; Christine M Bunck; Tonie E Rocke
Journal:  Ecohealth       Date:  2012-07-31       Impact factor: 4.464

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.